Active	Status	Sponsor type	Region	Phase	Filter
20 Active 19 Inactive 39 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Paepke, Stefan
NCT05142787: Magseed Pro(R)/ Sentimag(R) Gen3	Recruiting	N/A	224	Europe	Magseed Pro(R) and Sentimag(R) Gen3 by Endomagnetics	Endomagnetics Ltd.	Breast Cancer	12/25	06/26
L
EMERALD, NCT05001737 / 2021-001577-24: Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE	Active, not recruiting	3	41	Europe, Canada, Japan, US, RoW	Emapalumab, NI-0501, emapalumab-lzsg, ATC code: L04AA39 (WHO)	Swedish Orphan Biovitrum	Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease, Systemic Lupus Erythematosus, SJIA, AOSD, MAS	06/24	09/25
Weindl, Adolf
No trials found
Köhler, Karsten
No trials found
Böhm, Birgit
No trials found
Janko, Kim
No trials found
Moebus, Lukas
No trials found
Gulde, Philipp Gulde
No trials found